`U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

     [ X ] QUARTERLY  REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE  SECURITIES
           EXCHANGE ACT OF 1934

                  For the quarterly period ended June 30, 2004

     [ ]  TRANSITION  REPORT  PURSUANT TO SECTION 13 OR 15(d) OF THE  SECURITIES
          EXCHANGE ACT OF 1934

         For the transition period from to Commission File No. 333-85460

                          Vibrant Health International
        (Exact name of small business issuer as specified in its charter)

                   Nevada                                  84-1595734
(State or other jurisdiction of incorporation  (IRS Employer Identification No.)
              or organization)

                8907 E. Chenango Ave, Greenwood Village, CO 80111
                    (Address of principal executive offices)

                                  303-713-1870
                           (Issuer's telephone number)

                                 Not Applicable
      (Former name, address and fiscal year, if changed since last report)

Check  whether  the issuer  (1) has filed all  reports  required  to be filed by
Section 13 or 15(d) of the Exchange  Act during the  preceding 12 months (or for
such shorter period that the issuer was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days. Yes [ X] No [
]

APPLICABLE  ONLY TO  ISSUERS  INVOLVED  IN  BANKRUPTCY  PROCEEDINGS  DURING  THE
PRECEDING FIVE YEARS:

Check whether the registrant has filed all documents and reports  required to be
filed by  Sections  12,  13,  or 15(d) of the  Exchange  Act  subsequent  to the
distribution of securities under a plan confirmed by a court. Yes [ ] No [ ]

APPLICABLE ONLY TO CORPORATE ISSUERS:

State the number of shares outstanding of each of the issuer's classes of common
equity, as of June 30, 2004: 4,360,600 shares of common stock, par value $.001

Transitional Small Business Format:  Yes [   ]  No [ X ]

                                   FORM 10-QSB
                          VIBRANT HEALTH INTERNATIONAL
                          (A Development Stage Company)
                                      INDEX


PART I.          Financial Information

Item 1.  Consolidated Financial Statements

Consolidated Balance Sheets, June 30, 2004 (unaudited) and December 31, 2003

Unaudited Consolidated Statements of Operations for the Three and Six Months
ended June 30, 2004 and 2003 and for the period from December 3, 1997
(inception) through June 30, 2004

Unaudited Consolidated Statement of Stockholders' Equity (Deficit) for the
period from December 3, 1997 (inception) through June 30, 2004

Unaudited Consolidated Statements of Cash Flows for the Six Months ended June
30, 2004 and 2003 and for the period from December 3, 1997 (inception) through
June 30, 2004.

Notes to Unaudited Consolidated Financial Statements

Item 2.  Management's Discussion and Analysis of Financial Condition or Plan of Operation

Item 3.  Controls and Procedures

PART II. Other Information

Item 1.  Legal Proceedings

Item 2.  Changes in Securities and Use of Proceeds

Item 6.  Exhibits and Reports on Form 8-K

Signatures

(Inapplicable items have been omitted)



PART I.

Financial Information

Item 1.  Financial Statements (unaudited)

In the opinion of management,  the accompanying  unaudited financial  statements
included in this Form 10-QSB reflect all adjustments  (consisting only of normal
recurring  accruals)  necessary  for a  fair  presentation  of  the  results  of
operations for the periods presented.  The results of operations for the periods
presented are not  necessarily  indicative of the results to be expected for the
full year.




          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (a Development Stage Company)


                           Consolidated Balance Sheet


                                                                         June 30,    December 31,
                                                                          2004           2003
                                                                         ---------    ---------
                                                                        (unaudited)
                                     Assets

Current assets
   Cash ..............................................................   $  12,621    $  20,232
   Accounts receivable ...............................................         605         --
   Prepaid expenses ..................................................         325         --
                                                                         ---------    ---------

Total assets .........................................................   $  13,551    $  20,232
                                                                         =========    =========

                 Liabilities and Stockholders' Equity (Deficit)
Current liabilities
   Accounts payable and accrued expenses .............................   $  15,631    $   8,883
                                                                         ---------    ---------
         Total current liabilities ...................................      15,631        8,883
                                                                         ---------    ---------

Commitments and contingencies

Stockholders' equity (deficit)
   Common stock, authorized 100,000,000 shares,
    $.001 par value; 4,360,600 shares issued and outstanding .........       4,361        4,361
   Additional paid-in capital ........................................     110,009      110,009
   Deficit accumulated during the development stage ..................    (116,450)    (103,021)
                                                                         ---------    ---------
         Total stockholders' equity (deficit) ........................      (2,080)      11,349
                                                                         ---------    ---------

Total liabilities and stockholders' equity (deficit) .................   $  13,551    $  20,232
                                                                         =========    =========


          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (a Development Stage Company)

                 Unaudited Consolidated Statements of Operations


                                                                                                                    For the Period
                                                                                                                   from December 3,
                                                                                                                   1997 (Inception)
                                           For the Three Months Ended             For the Six Months Ended              through
                                        June 30, 2004      June 30, 2003      June 30, 2004       June 30, 2003      June 30, 2004
                                         (unaudited)        (unaudited)        (unaudited)         (unaudited)        (unaudited)

Sales                                   $       10,318     $        8,685     $       13,294      $       12,994     $       64,915

Cost of goods sold                               3,319              2,821              4,273               3,858             20,765
                                        --------------     --------------     --------------      --------------     --------------

Gross profit                                     6,999              5,864              9,021               9,136             44,150
                                        --------------     --------------     --------------      --------------     --------------

Operating expenses
   Website development costs                         -                  -                  -                   -             13,844
   General and administrative
    expenses                                     7,367             13,365             22,496              31,989            142,430
                                        --------------     --------------     --------------      --------------     --------------
     Total operating expenses                    7,367             13,365             22,496              31,989            156,274
                                        --------------     --------------     --------------      --------------     --------------

Loss from operations                              (368)            (7,501)           (13,475)            (22,853)          (112,124)

Interest expense                                    -                  -                  -                   -              (4,747)
Interest income                                     15                 86                 46                 193                421
                                        --------------     --------------     --------------      --------------     --------------

Net loss                                $         (353)    $       (7,415)    $      (13,429)     $      (22,660)    $     (116,450)
                                        ==============     ==============     ==============      ==============     ==============

Earnings (loss) per share - basic
 and diluted                            $       (0.000)    $       (0.002)    $       (0.003)     $       (0.005)
                                        ==============     ==============     ==============      ==============

Weighted average shares outstanding          4,360,600          4,360,600          4,360,600           4,360,600
                                        ==============     ==============     ==============      ==============





          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (a Development Stage Company)

       Unaudited Consolidated Statement of Stockholders' Equity (Deficit)
     For the Period from December 3, 1997 (Inception) through June 30, 2004


                                                                                               Deficit
                                                                                             Accumulated           Total
                                                                           Additional        During the        Stockholders'
                                                Common Stock                 Paid-In         Development           Equity
                                          Shares            Amount           Capital            Stage            (Deficit)
                                       --------------   --------------    --------------   ---------------    ---------------

Balance - December 3, 1997
  (Inception)                                      -    $           -     $           -    $            -     $            -

Stock issued                                4,360,600            4,361           110,009                -             114,370

Net loss for periods                               -                -                 -            (67,233)           (67,233)
                                       --------------   --------------    --------------   ---------------    ---------------

Balance - December 31, 2002                 4,360,600             4,361          110,009           (67,233)            47,137

Net loss                                           -                -                 -            (35,788)           (35,788)
                                       --------------   --------------    --------------   ---------------    ---------------

Balance - December 31, 2003                 4,360,600             4,361          110,009          (103,021)            11,349

Net loss                                           -                -                 -            (13,429)           (13,429)
                                       --------------   --------------    --------------   ---------------    ---------------

Balance - June 30, 2004                     4,360,600   $        4,361    $      110,009   $      (116,450)   $        (2,080)
                                       ==============   ==============    ==============   ===============    ===============





          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (a Development Stage Company)

                 Unaudited Consolidated Statements of Cash Flows

                                                                                        For the Period
                                                                                             from
                                                                                          December 3,
                                                               For the Six Months Ended      1997
                                                                        June 30,         (Inception) to
                                                                 ----------------------     June 30,
                                                                    2004         2003        2004
                                                                 ---------    ---------    ---------
                                                                 (unaudited)  (unaudited) (unaudited)
Cash flows from operating activities
   Net loss ..................................................   $ (13,429)   $ (22,660)   $(116,450)
   Adjustments  to  reconcile  net  loss to net  cash  used in
    operating activities
     Common stock issued for interest expense ................        --           --            750
     Changes in operating assets and liabilities
     Accounts receivable .....................................        (605)        --           (605)
     Prepaid expenses ........................................        (325)        --           (325)
     Accounts payable and accrued expenses ...................       6,748       (3,148)      15,631
                                                                 ---------    ---------    ---------
         Net cash used by operating activities ...............      (7,611)     (19,512)    (100,999)
                                                                 ---------    ---------    ---------

Cash flows from financing activities
   Proceeds from issuance of common stock ....................        --           --        113,620
                                                                 ---------    ---------    ---------
         Net cash provided by financing activities ...........        --           --        113,620
                                                                 ---------    ---------    ---------

Net (decrease) increase in cash ..............................      (7,611)     (19,512)      12,621

Cash, beginning of period ....................................      20,232       49,028         --
                                                                 ---------    ---------    ---------

Cash, end of period ..........................................   $  12,621    $  29,516    $  12,621
                                                                 =========    =========    =========




          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (A Development Stage Company)

              Notes to Unaudited Consolidated Financial Statements


Note 1 - Organization and Summary of Significant Accounting Policies

Vibrant  Health  International  (the  Company)  was  formed on July 9, 2001 as a
Nevada company.  The Company's  business  operations and contracts are primarily
conducted by its wholly owned subsidiary, Vibrant Health, Inc.

Vibrant  Health,  Inc.  was formed on  December  3, 1997 as a Colorado  company.
Vibrant  Health,  Inc. is a supplier and  distributor of health and  nutritional
products via use of the Internet. Operations since inception consist principally
of setting up the Company,  developing the Company's websites,  and commencement
of initial product sales.

On July 9, 2001, the Company issued 2,910,000 shares of common stock in exchange
for 100% of the  outstanding  shares of Vibrant  Health,  Inc. Due to the common
ownership  of  the   companies,   the   acquisition   was  accounted  for  as  a
recapitalization of Vibrant Health, Inc.



Note 2 - Liquidity and Management's Plans

The Company has incurred  accumulated losses of approximately  $116,000 from the
inception of Vibrant Health  International  through June 30, 2004.  These losses
and the significant future cash requirements  related to developing the business
indicate  substantial  doubt that the Company may be able to continue as a going
concern unless additional  capital is obtained or future  profitable  operations
are achieved.

During 2002, the Company completed a Form SB-2 Registration  Statement under the
Securities  Act of 1933.  The  offering  was  closed in  October  2002 and total
proceeds of $106,400 were released to the Company from escrow. In the opinion of
management,  with the resources currently available, the Company will be able to
maintain  its  operations  through June 30, 2005.  However,  management  is also
considering other options with respect to financing and reorganization.





Item 2. Management's Discussion and Analysis of Financial Condition or Plan of Operation

FORWARD-LOOKING STATEMENTS

This  Quarterly  Report  on Form  10-QSB  contains  forward-looking  statements.
Additional written or oral forward-looking statements may be made by the Company
from time to time in filings  with the  Securities  and Exchange  Commission  or
otherwise.  The words  "believe,"  "expect,"  "seek," and  "intend"  and similar
expressions identify forward-looking statements, which speak only as of the date
the statement is made. Such forward-looking statements are within the meaning of
that term in Section 27A of the Securities Act of 1933, as amended,  and Section
21E of the  Securities  Exchange Act of 1934, as amended.  Such  statements  may
include,  but are not limited to,  projections of income or loss,  expenditures,
acquisitions,  plans for future operations, financing needs or plans relating to
services of the  Company,  as well as  assumptions  relating  to the  foregoing.
Forward-looking  statements are inherently  subject to risks and  uncertainties,
some of which  cannot be  predicted  or  quantified.  Future  events  and actual
results  could differ  materially  from those set forth in,  contemplated  by or
underlying the forward-looking statements.

The Company does not undertake,  and specifically  disclaims,  any obligation to
publicly release the results of revisions,  which may be made to forward-looking
statements to reflect the occurrence of anticipated or  unanticipated  events or
circumstances after such statements.

General

We were  incorporated  in Nevada on July 9, 2001. We are a distributor of health
and nutritional products. We distribute healthcare products to our customers via
orders  generated on our  Internet  addresses,  www.vibranthealthonline.com  and
www.yahoovibranthealth.com.   Our  current   business   operations  and  related
operational  contracts  are being  conducted  by our  wholly  owned  subsidiary,
Vibrant Health, Inc., a Colorado corporation.


Our Business

We distribute  health and nutritional  products.  We are a distribution  company
only and do not have any expertise in nutritional science or manufacturing.  The
name Vibrant  Health does not reflect  health  expertise but rather is marketing
oriented,  and was  selected  to  instill in our  customers  a feeling of vigor,
energy,  and  motivation,  with the clarifying  word of health  pinpointing  our
product focus.  We believe that  individuals  with such feelings will understand
the value of fitness and appreciate the value of our products.

We are focusing our  marketing  efforts in generating  sales orders  through our
Internet website. We previously had two separate websites. In the second quarter
of 2004,  we  consolidated  our Internet  presence  into one website,  but it is
accessible  using  each of the two  previously  known  Internet  addresses.  Our
website    can    be     accessed     via     www.vibranthealthonline.com     or
www.yahoovibranthealth.com.


We will accept  ancillary  orders when they are  available  to us by  facsimile,
email,  phone calls,  or mail.  However,  our  promotional  materials  generally
advocate  and guide the  potential  customer to route orders for our product via
our  website.   Our  website  is  fully  operational,   however,  we  intend  to
continuously update and refine our website.

We do not  manufacture  the products  that we sell.  Instead,  we contract  with
health and nutritional product formulators who specialize in supplying products.
Our plan, as order volume increases, will be to out-source our order fulfillment
operations so that we can focus on the marketing and sale of our products.

We have a five-year agreement that expires October 2006 with Imagenetix, Inc., a
company  located in  southern  California,  to supply us with their  proprietary
products. They have experience in packaging and supplying health and nutritional
products.  They assist us in choosing a few select  products of theirs that they
believe are their highest quality products,  with large potential  markets,  and
with profit margins that would warrant our attention.

We selected  Imagenetix,  Inc. because they are established in the nutrition and
natural health product area. If we were to lose this agreement with  Imagenetix,
Inc., our ability to obtain a supply of quality product on favorable terms would
probably  be greatly  hampered.  We believe  that we would be able to find other
suppliers,  but that they would require a greater expenditure of management time
and that profit margins on sales may decrease.

Our website currently list two products for sale. Each is a form of Imagenetix's
proprietary product,  Celadrin(R). We market a cream form of Celadrin(R)in a jar
and an oral capsules form of this product in a bottle.  We place a label on each
product sold identifying the product as either Vibrant Creme or Vibrant Celcaps.
We have no exclusivity with respect to any of these products. In fact, there are
several  distributors  that market other private  label forms of these  products
through their marketing organizations.

Celadrin(R)is a scientifically  tested  formulated  product developed to provide
support  for healthy  joint  function  and  mobility.  Celadrin(R)consists  of a
complex of scientifically targeted fatty acid esters.  Celadrin(R)was  subjected
to clinical studies. The results of the studies were published in The Journal of
Rheumatology.

Recently  Avon  Products,  Inc. has  commenced  selling a cream  product,  which
contains  Celadrin(R).  Avon's product has a sales price, which is substantially
lower than our topical cream containing Celadrin(R).  As a result, the extent to
which our sales are enhanced by media coverage of the  Celadrin(R)product is now
substantially less.

We are supplying products under our own Vibrant Health brand name. Imbedding the
Vibrant Health name as part of the product title may significantly  increase the
name  recognition of both the product and the Company and assist the customer to
associate it with quality and value.  Costs  associated  with labeling  products
with our name are  minimal  and  consist of  printing  new  labels  for  product
containers.

Three-Month Periods Ended June 30, 2004 and 2003

The Company had $10,318 in sales for the three month  period ended June 30, 2004
and sales of $8,685 for the same  three-month  period in 2003. Sales were higher
in the quarter  ended June 30, 2004 because of recent  publicity  regarding  the
Company's  product.  Cost of goods sold was $3,319  for the  three-month  period
ended June 30, 2004 compared to $2,821 for the same period in 2003.  The Company
had a gross profit of $6,999 for the three  months ended June 30, 2004  compared
to $5,864 for the same period in 2003.

Operating  expenses  for the three month  period ended June 30, 2004 were $7,367
compared to $13,365 for the same period in 2003.  Expenses  consisted of general
corporate  administration,  legal  and  professional  expenses,  accounting  and
auditing costs,  and in 2003 included wages.  Decreased  expenses for the period
ended June 30, 2004 were  primarily  because the officer has suspended his wages
until such time as when the company's financial position improves.

As a result of the foregoing  factors,  the Company  realized a net loss of $353
for the three  months  ended June 30, 2004 as compared to net loss of $7,415 for
the same period in 2003.


Six-Month Periods Ended June 30, 2004 and 2003

The Company had  $13,294 in sales for the six month  period  ended June 30, 2004
and sales of $12,994 for the same six-month  period in 2003.  Cost of goods sold
was $4,273 for the  six-month  period ended June 30, 2004 compared to $3,858 for
the same period in 2003.  The  Company had a gross  profit of $9,021 for the six
months ended June 30, 2004 compared to $9,136 for the same period in 2003.

Operating  expenses  for the six month  period  ended June 30, 2004 were $22,496
compared to $31,989 for the same period in 2003.  Expenses  consisted of general
corporate  administration,  legal and professional  expenses, and accounting and
auditing costs,  and in 2003 included wages.  Decreased  expenses for the period
ended June 30, 2004 were  primarily  because the officer has suspended his wages
until such time as when the company's financial position improves.

As a result of the foregoing factors, the Company realized a net loss of $13,429
for the six months  ended June 30,  2004 as  compared to net loss of $22,660 for
the same period in 2003.

Liquidity and Capital Resources

At June 30, 2004, the Company had assets totaling $13,551,  mostly consisting of
cash on hand.  Current  liabilities  consisted  of accounts  payable and accrued
expenses  of  $15,631.   The  Company  does  not  have  any  long-term   capital
commitments.

The Company  believes  that its  current  cash needs can be met with the cash on
hand and current  operations.  The Company's  initial public  offering closed in
October 2002 and generated proceeds of $106,400. All of these proceeds have been
expended as of June 30,  2004.  Should the Company  find it  necessary  to raise
additional  capital,  the Company may sell common  stock of the Company or enter
into debt financing agreements.


Item 3. Controls and Procedures

Our Chief  Executive  Officer  and Chief  Financial  Officer has  evaluated  the
effectiveness  of our disclosure  controls and procedures (as such is defined in
Rules  13a-13(c) and 15d-14(c))  under the  Securities  Exchange Act of 1934, as
amended (the "Exchange Act"), as of the period covered by this report.  Based on
such  evaluation,  such officers have  concluded  that, as of June 30, 2004, our
disclosures  and  procedures are effective in alerting them on a timely basis to
material   information   relating  to  our  Company  (including  our  controlled
subsidiary)  required to be included in our reports filed or submitted under the
Exchange Act.

During the period  covered by this report,  there have not been any  significant
changes in our internal controls that have materially affected or are reasonably
likely to materially affect, our internal controls over financial reporting.

Part II: OTHER INFORMATION

Item 1. Legal Proceedings

The  Company is not a party  defendant  in any  material  pending or  threatened
litigation  and to its  knowledge,  no  action,  suit or  proceedings  has  been
threatened against its officers and its directors.

Item 2.  Changes in Securities and Use of Proceeds

On July 9, 2001, we issued a total of 2,959,000 common shares to our founder and
President,  Thomas  H.  McAdam  in  connection  with  beginning  operations  and
acquiring our subsidiary. The shares were issued as follows: 100,000 shares were
issued  in  exchange  for  $1,000  cash.  2,109,000  shares  of  Vibrant  Health
International  common  stock were issued and  exchanged  for  703,000  shares of
Vibrant Health, Inc. common stock.  750,000 shares were issued,  valued at $750,
in  consideration  of  receiving a $15,000  loan.  The  securities  were sold in
private transactions, without registration in reliance on the exemption provided
by Section 4(2) of the  Securities  Act. The investor had access to all material
information pertaining to the Company and its financial condition.  The investor
completed and signed a subscription agreement attesting to his sophistication or
accredited  investor status and investment intent. No broker was involved and no
commissions were paid in the transactions.

Also on July 9, 2001, we issued  801,000  shares valued at $801 to a shareholder
in exchange for 267,000 shares of Vibrant Health,  Inc. The securities were sold
in a private  transaction,  without  registration  in reliance on the  exemption
provided by Section 4(2) of the  Securities  Act. The investor had access to all
material  information  pertaining to the Company and its financial condition and
the investor  completed  and signed a  subscription  agreement  attesting to his
sophistication  or accredited  investor status and investment  intent. No broker
was involved and no commissions were paid in the transactions.

On August 27,  2001,  Mr.  McAdam  purchased  550,000  shares of Vibrant  Health
International common stock from a shareholder for $550 in a private transaction,
bringing Mr. McAdam's total ownership to 3,509,000 shares of common stock.

In September  2001, we issued  175,000  shares of common stock to two accredited
investors  for  a  total  of  $5,250.   The  securities  were  sold  in  private
transactions,  without  registration  in reliance on the  exemption  provided by
Section 4(2) of the  Securities  Act.  Each  investor had access to all material
information pertaining to the Company and its financial condition. Each investor
completed and signed a subscription agreement attesting to his sophistication or
accredited  investor status and investment intent. No broker was involved and no
commissions were paid in the transactions.

On  March  29,  2004,   Mr.  McAdam  gifted  60,000  shares  of  Vibrant  Health
International  to family  members,  bringing  Mr.  McAdam's  total  ownership to
3,449,000  shares,  or  approximately  79% of our total  issued and  outstanding
common stock.

The  Company  filed  an SB-2  Registration  Statement  with the  Securities  and
Exchange  Commission  offering  a minimum  of  350,000  shares  and a maximum of
800,000 shares at $0.25 per share.  The offering  became  effective on August 2,
2002 and closed on October 22,  2002.  The Company  successfully  completed  the
offering  of 425,600  shares of common  stock to 44  shareholders  and  received
proceeds  of  $106,400.  The  Company  incurred  expenses  included  legal fees,
accounting fees,  escrow fees,  filing fees,  printing and transfer agent costs.
The Company  also  repaid  loans and  interest.  All of the  proceeds  have been
expended as of June 30, 2004





Item 6. Exhibits and Reports on Form 8-K

Reports on Form 8-K:

No reports on Form 8-K were filed by Vibrant Health International during the three months ended June 30, 2004.

Exhibits:

Exhibit       Title                                                                        Location
Number

31            Certification of the Chief Executive Officer and Chief Financial Officer     Attached
              pursuant to Rule 13a-15(e)/15d-15(e)

32            Certification of the Chief Executive Officer and Chief Financial Officer     Attached
              pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
              the Sarbanes-Oxley Act of 2002





                                   SIGNATURES


Pursuant to the  requirements of the Securities  Exchange Act of 1934, this Form
10-QSB Report, for the Quarter ended June 30, 2004, has been signed below by the
following person on behalf of the Registrant and in the capacity and on the date
indicated.



                                                    VIBRANT HEALTH INTERNATIONAL

July 22, 2004                                       By       /s/Thomas H. McAdam
                                                             -------------------
                                                                Thomas H. McAdam
                                                                Chief Executive Officer and
                                                                Chief Financial Officer`